Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Based on Phase 2 studies, the initial dose may begin at 1 mg to 2 mg (0.0750.15 mL) once weekly, with gradual titration every 4 weeks in increments of 2 mg to 4 mg, as tolerated, up to a maximum of 12 mg (0.90 mL) weekly Doses between 4 mg and 12 mg weekly demonstrated meaningful reductions in body weight and glycemic parameters over 16 to 28 weeks
Retatrutide (LY-3437943) is an innovative research peptide that is increasingly gaining popularity within scientific communities across the UK and worldwide
That is the molecule used in Ozempic for type 2 diabetes and Wegovy for obesity
[PMID: 1875044] PubMed record related to this compound for laboratory literature review
Right formulation, right indication, right patient
GoalBMI Wellness offers secure telehealth consultations for eligible patients interested in currently available medical weight-loss programs
US$ 28.19
US$ 28.47
US$ 25.60
US$ 27.64
